Canadian Group Plan Renewal with a Disability and EI Gap

Structural (recurring) drivers:

• Plan design with no cost-sharing: 100% drug coverage with no deductible, no annual maximum, and no managed formulary means the plan absorbs every unit-cost increase and every new specialty launch. That is a design choice, not a trend event.
• Specialty drug mix: two claimants driving roughly $500k+ of a $1.15M drug book means the plan has a concentration problem that will recur as more biologics launch.
• Disability duration, not incidence: LTD premium is priced on long-term duration. Two second-year mental-health claims and 22 absences point to a return-to-work and early-intervention gap, not a claims spike.
• 17-week LTD waiting period: EI sickness benefits run a maximum of 15 weeks, leaving a two-week hole with no income. That hole encourages longer absence and pushes cases into LTD.

One-time or volatile: any single high-cost claimant, a neonatal case, or a one-off pooling charge.

Evidence needed before design change: three years of drug claims by therapeutic class and claimant, pooling-charge history and deficit recovery in the rate, LTD incidence and duration by diagnosis and by manager, absence data, and provincial comparisons. With only 650 lives, one or two claimants can drive the whole renewal - the CHRO must see the renewal with and without the large claims before agreeing that a 21.4% increase is a trend problem.

Package (in order of value):

1. Drug plan redesign: 20% coinsurance up to an annual out-of-pocket cap (e.g., $1,500 per family), mandatory generic substitution, prior authorization and biosimilar-first for the two specialty classes, and a managed formulary with a defined exception process. Expected value: the largest, because it changes the unit economics of 28% of premium.
2. Health Care Spending Account funded by design savings: convert part of the coinsurance into an HCSA credit (e.g., $600 per employee). Employees see the same total support; the employer captures the difference between first-dollar coverage and capped coverage.
3. Paramedical: keep the $500 but add a per-discipline cap or a $25 co-pay per visit; this is low-cost and low-risk.
4. LTD: reduce the waiting period from 17 to 15 weeks to align with EI sickness benefits, add an early-intervention/RTW program, and consider a rehabilitation incentive. A shorter waiting period costs premium but is usually more than offset by shorter duration.
5. Mental health: add a formal EAP with rapid access to counselling and a psychological services benefit with a separate maximum.

Constraints:

• Provincial health plans do not cover most outpatient drugs, so the employer plan is primary; capping drug coverage must not effectively deny medically necessary treatment to a person with a disability. Build a documented accommodation process (Ontario Human Rights Code) and an exception route to the Trillium catastrophic program or manufacturer support programs.
• Group contracts and insurer notice periods govern implementation date; changing coverage mid-contract requires insurer agreement.
• Alberta members may sit under a different provincial contract and different rules.

Result: the package realistically lands near 5% by shifting pharmacy trend and duration rather than cutting headline benefits.

The gap. EI sickness benefits pay roughly 55% of insurable earnings to a maximum for a maximum of 15 weeks. A 17-week LTD waiting period leaves two weeks with no income at all, which drives employees toward longer absences and, in practice, toward a contested LTD claim.

Fix, in sequence:

1. Align the waiting period to 15 weeks (or bridge the two weeks with a taxable employer sick-pay top-up), so income is continuous from day one of absence.
2. Apply for EI at the start of absence, not at week 15. Coordinate the LTD benefit so EI is offset but the employee is not penalized for applying late.
3. Early intervention at 4–6 weeks: nurse case manager contact, treatment plan confirmation, and accommodation planning with the manager.
4. Return-to-work protocol: graded hours, temporary modified duties, and a written accommodation process. An employer cannot simply wait for a doctor's note; the duty to accommodate to the point of undue hardship applies.
5. Mental health pathway: EAP, rapid counselling, and a manager-training component, since the two long claims are psychological.

Measure: absence incidence per 100 employees, average duration by diagnosis, percentage of absences converted to LTD, RTW success at 3/6/12 months, EI take-up rate, drug cost per claimant and specialty-drug share, and the plan's loss ratio with and without large claims. Review quarterly with the insurer and annually with the CHRO, and report on the accommodation log so design changes can be tested against actual need rather than assumption.